Volitionrx Ltd (VNRX)

3.10
-0.06(-1.90%)
After Hours
3.10
0.00(0.00%)
- Real-time Data
  • Volume:
    130,222
  • Bid/Ask:
    3.00/3.50
  • Day's Range:
    3.05 - 3.15

VNRX Overview

Prev. Close
3.16
Day's Range
3.05 - 3.15
Revenue
20K
Open
3.16
52 wk Range
2.79 - 6.67
EPS
-0.46
Volume
130,222
Market Cap
163.97M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
409,201
P/E Ratio
-
Beta
1.79
1-Year Change
-25.84%
Shares Outstanding
52,892,713
Next Earnings Date
May 13, 2021
What is your sentiment on Volitionrx Ltd?
or
Market is currently closed. Voting is open during market hours.

Volitionrx Ltd News

Volitionrx Ltd Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryBuyBuyStrong SellStrong SellStrong Sell

Volitionrx Ltd Company Profile

Volitionrx Ltd Company Profile

Sector
Financial
Employees
65

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.

Read More
  • Promete!
    0
    • will be around 5 very soon
      0
      • Whats the reason Mauro
        0
    • VolitionRx: Nu.Q Shows Correlation With Disease Severity In COVID-19 Patients
      0
      • This will fly today
        0
        • VolitionRx up big on encouraging COVID-19 test data
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.